Search Results for "Micrus Endovascular Merger"

08:20 EST 28th November 2014 | BioPortfolio

Original Source: Micrus Endovascular Corporation

Micrus develops, manufactures and markets implantable and disposable medical devices for use in the treatment of cerebral vascular diseases. Micrus products are used by interventional neuroradiologists, interventional neurologists and endovascularly trained neurosurgeons to treat both cerebral aneurysms responsible for hemorrhagic stroke and intracranial atherosclerosis, which may lead to ischemic stroke. Hemorrhagic and ischemic stroke are both significant c...

Matching Channels

Jobs in Endovascular

Aorfix

Aorfix™ endovascular stent graft – Treating the cases other grafts cannot treat Aorfix™ is the only endovascular stent graft licensed in Europe to treat aneurysms in complex anat...

Boston Scientific

Boston Scientific is a global medical device company, the 8th largest (based on annual sales, which were over $8 billion in 2010). It is the world's second largest maker of heart devices; prod...

Matching News

[Articles] The durability of endovascular coiling versus neurosurgical clipping of ruptured cerebral aneurysms: 18 year follow-up of the UK cohort of the International Subarachnoid Aneurysm Trial (ISAT)

Although rates of increased dependency alone did not differ between groups, the probability of death or dependency was significantly greater in the neurosurgical group than in the endovascular group. ...

'MR CLEAN' Polishes Stroke Outcome With Endovascular Therapy

Endovascular therapy on top of intravenous thrombolytic was safe and effective in improving functional outcomes in anterior circulation strokes, a study showed. Benefit occurred even for the oldest pa...

Nellix® EndoVascular Aneurysm Sealing System for abdominal aortic aneurysm repair

The Nellix® EndoVascular Aneurysm Sealing System (EVAS) has been developed by Endologix, Inc. for the endovascular repair of infrarenal abdominal aortic aneurysms (AAA). The system is designed to com...

BioNotebook: Seven deals and updates, including 190 pre-merger layoffs at Auxilium

Auxilium cutting 190 jobs ahead of QLT merger; Cempra gets $10m milestone payment; Ligand, CURx sign license deal; Telik will soon be MabVax after merger; Ophthotech earns $50m fee from Novartis; Mome...

Endovascular Stroke Trials Halted for Benefit

Two further trials of embolectomy device trials have been stopped early because of benefit in the endovascular treatment group. A third trial has been put on temporary hold for an early interim analys...

Game Changer for Endovascular Treatment of Ischemic Stroke?

Studies have failed to provide evidence that endovascular treatment is superior to medical treatment of acute ischemic stroke, but new devices and techniques may change that. Journal of Neurointerve...

Are Questcor Shareholders Getting A Good Deal?

ByIAEResearch:In April, Questcor (NASDAQ:QCOR) announced a merger with Mallinckrodt (NYSE:MNK) - effectively, Mallinckrodt will buy Questcor and absorb its product - Mallinckrodt shareholders will rem...

Lombard Medical Technologies???s Aorfix? Endovascular Stent Graft Adopted By Surgeons At Veteran Affairs Medical Centers

Lombard Medicals Aorfix? Endovascular Stent Graft Adopted By Surgeons At Veteran Affairs Medical Centers Irvine, CA and London, UK October 9, 2014 Lombard Medical, Inc. (NASDAQ: EVAR), a medical dev...

Matching PubMed Articles

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement